ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

57
Analysis
Health Care • Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
Exchange Announcement • 17 Sep 2026 14:30

Presentation For Financial Results For The 2nd Quarter Of The Fiscal Year Ending January 31, 2027

Exchange Announcement • 15 Sep 2026 14:30

[Delayed] Consolidated Financial Results For The Six Months Ended July 31, 2026 [Japanese Gaap]

Exchange Announcement • 15 Sep 2026 14:30

[Delayed] Notice Concerning Differences Between The Consolidated Earnings Forecast And Actual Results For 2q Of The Fiscal Year Ending January 31, 2027

Exchange Announcement • 14 Sep 2026 14:30

Notice Concerning Recording Of Non-Operating Income,Non-Operating Expenses And Deferred Income Taxes

Exchange Announcement • 07 Sep 2026 14:30

[Delayed] Notice Regarding Integration Of Akuugo (R) Manufacturing Operations In Japan Following Closure Of Minaris’ U.S. Facility

x